Capital World Investors
ACHN

Capital World Investors’s Achillion Pharmaceuticals ACHN Stock Holding History

Capital World Investors’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,325,000
Closed -$22.9M – 551
2015
Q1 		$22.9M Sell
2,325,000
-125,000
-5% -$1.56M 0.01% 431
2014
Q4 		$30M Sell
2,450,000
-2,480,000
-50% -$30.3M 0.01% 412
2014
Q3 		$49.2M Buy
4,930,000
+800,000
+19% +$7.43M 0.01% 372
2014
Q2 		$31.3M Hold
4,130,000
– – 0.01% 396
2014
Q1 		$13.6M Hold
4,130,000
– – ﹤0.01% 448
2013
Q4 		$13.7M Hold
4,130,000
– – ﹤0.01% 439
2013
Q3 		$12.5M Buy
4,130,000
+455,000
+12% +$3.12M ﹤0.01% 439
2013
Q2 		$30.1M Buy
+3,675,000
New +$28.1M 0.01% 371

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Capital World Investors's ACHN Position: Q2 2015 in Review

Capital World Investors sold out of Achillion Pharmaceuticals (ACHN) in Q2 2015, closing a stake of 2,325,000 shares — an estimated $22.9M sold.

Capital World Investors first reported a position in ACHN in Q2 2013 and held it in 8 quarters. The position peaked at $49.2M in Q3 2014. 158 funds tracked by Wall St. Rank hold ACHN as of Q2 2015.

  • Capital World Investors reported no remaining Achillion Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Capital World Investors sold 2,325,000 Achillion Pharmaceuticals shares in Q2 2015, an estimated $22.9M.
  • Capital World Investors first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 8 quarters.
  • Capital World Investors's Achillion Pharmaceuticals position peaked at $49.2M in Q3 2014.
  • 158 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q2 2015.

Based on Capital World Investors's 13F filing for Q2 2015, filed 14 Aug 2015.